DE3267160D1 - Process for producing capsular polyosides, capsular polyosides so obtained and their use in the preparation of vaccines - Google Patents

Process for producing capsular polyosides, capsular polyosides so obtained and their use in the preparation of vaccines

Info

Publication number
DE3267160D1
DE3267160D1 DE8282401343T DE3267160T DE3267160D1 DE 3267160 D1 DE3267160 D1 DE 3267160D1 DE 8282401343 T DE8282401343 T DE 8282401343T DE 3267160 T DE3267160 T DE 3267160T DE 3267160 D1 DE3267160 D1 DE 3267160D1
Authority
DE
Germany
Prior art keywords
capsular
polyosides
bacteriae
give
retained material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282401343T
Other languages
English (en)
Inventor
Demetre Institut De Yavordios
Mireille Institut De Re Cousin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BERRI BALZAC
Original Assignee
BERRI BALZAC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BERRI BALZAC filed Critical BERRI BALZAC
Application granted granted Critical
Publication of DE3267160D1 publication Critical patent/DE3267160D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
DE8282401343T 1981-07-30 1982-07-19 Process for producing capsular polyosides, capsular polyosides so obtained and their use in the preparation of vaccines Expired DE3267160D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8114842A FR2510606A1 (fr) 1981-07-30 1981-07-30 Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins

Publications (1)

Publication Number Publication Date
DE3267160D1 true DE3267160D1 (en) 1985-12-05

Family

ID=9261011

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282401343T Expired DE3267160D1 (en) 1981-07-30 1982-07-19 Process for producing capsular polyosides, capsular polyosides so obtained and their use in the preparation of vaccines

Country Status (11)

Country Link
EP (1) EP0071515B1 (de)
AT (1) ATE16244T1 (de)
CA (1) CA1206905A (de)
DD (1) DD202623A5 (de)
DE (1) DE3267160D1 (de)
DK (1) DK327182A (de)
ES (1) ES8305827A1 (de)
FR (1) FR2510606A1 (de)
IE (1) IE53582B1 (de)
NO (1) NO159394C (de)
PT (1) PT75301B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683844D1 (de) * 1986-03-27 1992-03-19 Schweiz Serum & Impfinst Impfstoff des klebsiella kapsulpolysaccharids.
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
EP1967591A3 (de) * 2000-03-16 2008-12-03 The Children's Hospital Of Philadelphia Methode zur Bestimmung der Nützlichkeit einer Testsubstanz zur Linderung einer Pneumokokken-Infektion in einem Tier
NZ511680A (en) 2001-05-14 2004-07-30 Univ Waikato Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
WO2008129559A2 (en) 2007-04-23 2008-10-30 Serum Institute Of India Ltd Antigenic polysaccharides and process for their preparation
WO2011148382A1 (en) 2010-05-28 2011-12-01 Biological E Limited An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
WO2011151841A1 (en) * 2010-05-31 2011-12-08 Panacea Biotec Limited Fermentation process for streptococcus pneumoniae
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CA3048981A1 (en) 2016-12-30 2018-07-05 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2024062494A1 (en) 2022-09-19 2024-03-28 Biological E Limited Method for the purification of capsular polysaccharides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166963A (en) * 1936-11-19 1939-07-25 Sharp & Dohme Inc Antigenic polysaccharide complex
US2528972A (en) * 1947-05-15 1950-11-07 Western Reserve University Prophylactic toxoid compound and method of making same
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4307080A (en) * 1979-09-24 1981-12-22 Merck & Co., Inc. Meningitis vaccine
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries

Also Published As

Publication number Publication date
IE821705L (en) 1983-01-30
FR2510606A1 (fr) 1983-02-04
ATE16244T1 (de) 1985-11-15
CA1206905A (en) 1986-07-02
EP0071515A1 (de) 1983-02-09
DK327182A (da) 1983-01-31
FR2510606B1 (de) 1984-10-26
NO159394C (no) 1988-12-21
DD202623A5 (de) 1983-09-28
IE53582B1 (en) 1988-12-21
PT75301B (fr) 1984-07-31
EP0071515B1 (de) 1985-10-30
PT75301A (fr) 1982-08-01
ES514496A0 (es) 1983-04-16
ES8305827A1 (es) 1983-04-16
NO159394B (no) 1988-09-12
NO822592L (no) 1983-01-31

Similar Documents

Publication Publication Date Title
DE3267160D1 (en) Process for producing capsular polyosides, capsular polyosides so obtained and their use in the preparation of vaccines
PH25945A (en) Improved process for transforming plant protoplasts
ATE91155T1 (de) Verfahren zur bereitung von nukleinsaeure fuer hybridisierung.
DE69109886D1 (de) Verfahren zur Herstellung von humanem Faktor VIII und dessen Analogen.
DE3369158D1 (en) Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions
FR2545099B1 (fr) Nouvelle souche de trichoderma harzianum procede d'isolement de cette souche, procede de culture de cette souche, nouveaux peptides produits par cette souche, et application de cette souche et ces nouveaux peptides ou du produit obtenu par le procede de culture comme moyen de lutte biologique sous forme de produit phytosanitaire
ATE57457T1 (de) Poroeses produkt fuer die pflanzenkultur und verfahren zu dessen herstellung.
DE3065316D1 (en) Process for the production of creatinine iminohydrolase by growing micro-organism and nutrient medium for the practice of said process
ATE21033T1 (de) Verfahren zur herstellung eines immunogens aus pasteurella multocida.
ATE132875T1 (de) Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung
EP0391345A3 (de) Verfahren zur Herstellung optisch aktiver Substanzen
JPS5528A (en) Preparation of coenzyme q9
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
EP0337625A3 (de) Proben
ATE2339T1 (de) Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung.
JPS5682095A (en) Purification of fatty acid produced through fermentation process
WO1990010058A3 (en) Method for production and purification of hepatitis b vaccine
JPS5592395A (en) Novel antibiotic substacne neopolyoxin, and its preparation
JPS5554898A (en) Preparation of 3-o-demethyl-fortimicin a
RU93028311A (ru) Способ получения биологически активных веществ из биомассы культивируемых клеток растений
JPS55165799A (en) Preparation of hopan-22-ol and hopene-b
JPS55102389A (en) Novel microorganism
JPS56124381A (en) Preparation of uricase by fermentation method
RO94493A2 (ro) Procedeu de preparare a unui mediu de cultivare a bacteriilor anaerobe
DE143850T1 (de) Physiologisch aktives proteinmaterial.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee